GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OSTO:BICO) » Definitions » EPS (Diluted)

BICO Group AB (OSTO:BICO) EPS (Diluted) : kr-24.43 (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is BICO Group AB EPS (Diluted)?

BICO Group AB's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was kr-3.49. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was kr-24.43.

BICO Group AB's EPS (Basic) for the three months ended in Sep. 2024 was kr-3.49. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was kr-24.43.

BICO Group AB's EPS without NRI for the three months ended in Sep. 2024 was kr-3.49. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was kr-27.46.

During the past 3 years, the average EPS without NRIGrowth Rate was -160.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, BICO Group AB's highest 3-Year average EPS without NRI Growth Rate was -160.50% per year. The lowest was -349.10% per year. And the median was -277.00% per year.


BICO Group AB EPS (Diluted) Historical Data

The historical data trend for BICO Group AB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB EPS (Diluted) Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial 0.02 -1.50 -3.97 -12.94 -28.10

BICO Group AB Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.99 -19.44 -0.40 -1.10 -3.49

Competitive Comparison of BICO Group AB's EPS (Diluted)

For the Medical Devices subindustry, BICO Group AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where BICO Group AB's PE Ratio falls into.



BICO Group AB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BICO Group AB's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1983.1-0)/73.078
=-27.14

BICO Group AB's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-246.2-0)/73.081
=-3.37

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BICO Group AB  (OSTO:BICO) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BICO Group AB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BICO Group AB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB Business Description

Traded in Other Exchanges
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. It is divided into three business areas: Bioprinting (CELLINK, MatTek, Visikol, and Nanoscribe), Biosciences (CYTENA, CYTENA Bioprocess Solutions, Dispendix, and Discover Echo), and Bioautomation (SCIENION, CELLENION, and Ginolis).

BICO Group AB Headlines

No Headlines